Phase-II, Multicenter, Randomized, Double-Blind, Parallel-Group Trial to Compare the Efficacy and Safety of Sorafenib Plus Pravastatin Against Sorafenib Plus Placebo in Patients With Advanced Hepatocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Pravastatin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 16 Nov 2016 This trial was completed in Spain, according to European Clinical Trials Database.
- 25 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 Aug 2011 New trial record